Edson X. Albuquerque,
M.D., Ph.D.  4l0-706-7333
Department of Pharmacology and Experimental Therapeutics
Research: Effects of endogenous substances, toxins and clinically relevant drugs on nicotinic receptor function and expression, synaptic transmission and synaptic plasticity in the brain.
|
Sania Amr,
M.D. 410-706-1466
Epidemiology and Preventive
Research: Environmental and occupational exposures and their roles in the development of chronic diseases
|
Larry Anderson,
Ph.D. 410-706-3989
Department of Anatomy and Neurobiology
Research: The two major research efforts in Dr. Anderson's laboratory are associated with reproduction. The first centers on the role of androgens in regulating various cellular and molecular characteristics involved in the growth, development, and differentiation of one compartment within the follicle of the ovary, the granulosa cells
|
Robert Anderson,
Ph.D. 410-326-7247
Chesapeake Biological Laboratory
Research: Comparative immunology and immunotoxicology of marine organisms; immunological basis of disease susceptibility and resistance.
|
Laure Aurelian,
Ph.D. 410-706-3895
Department of Pharmacology and Experimental Therapeutics
Research: Ongoing studies are focused on understanding the molecular mechanism of H11 induced apoptosis, its regulation and its role in melanoma development.
|
Caroline Baier-Anderson,
Ph.D. 410-706-8196
Epidemiology and Preventive Medicine
Research: Chemical health risk analysis and exposure assessment.
|
Angela Brodie,
Ph.D. 410-706-3137
Pharmacology & Experimental Therapeutics
Research: Molecular Mechanism Involved in the Response of Breast and Prostate Cancer to Endocrine Treatment: Development and Optimization of Novel Therapies.
|
Gary Fiskum,
Ph.D. 410-706-4711
Departments of Anesthesiology, Biochemistry & Molecular Biology, and Pharmacology & Experimental Therapeutics
Research: Our research focuses on the molecular mechanisms responsible for neurodegeneration with emphasis on ischemic and traumatic brain injury and Parkinson's Disease.
|
Douglas O. Frost,
Ph.D. 410-706-0413
Department of Pharmacology and Experimental Therapeutics
Department of Anesthesiology
Research: Cellular and molecular mechanisms underlying normal neural development and the perturbation of these mechanisms in disease states or by drugs. We also study how these mechanisms can be harnessed for brain repair.
|
Averell Gnatt,
Ph.D.
Department of Pharmacology
Research: Eukaryotic transcription; mammalian transcription; cancer
|
M. Samir Jafri,
Ph.D. 410-706-2384
Neurology
Research: 1) Organotypic nigrostriatal cultures to study neurodegeneration and neuroprotection 2) Translational neurosurgical project using novel optical imaging to target stem cell and gene therapy delivery.
|
Anil Jaiswal,
Ph.D. 410-706-2285
Pharmocology and Experimental Therapeutics
Research: Our research interests include 'Oxidative Stress Signaling, Cell Survival and Death, Chemoprevention, Oncogenesis and Bioreductive Drug Activation and Drug Development'.
|
Laundette Jones,
Ph.D. 410-706-7331
Pharmacology and Experimental Therapeutics
Research: Genetic and Environmental Modifiers of Breast Cancer risk; Environmental Toxicology; Mechanisms of Chemical Carcinogenesis
|
William LaCourse,
Ph.D. 410-455-2105
Chemistry and Biochemistry, UM Baltimore County
Research: Research interests include basic and applied research on hydrodynamic electroanalytical techniques in liquid chromatography and capillary electrophoresis. Bioanalytical problems of critical significance lie in the areas of pharmaceutical, toxicological, forensic, environmental, pharmaceutical, and life science arenas.
|
Barry Levine,
Ph.D. 410-333-3240
Maryland Medical Examiners Office, Department of Pathology
Research: Analytical methods for forensic toxicology.
|
Michael Lipsky,
Ph.D. 410-706-7276
Pathology
Research: Renal and hepatic toxicity of metals.
|
Frank L. Margolis,
Ph.D. 410-706-8913
Department of Anatomy & Neurobiology
Research: One of the major goals of my laboratory is to identify and characterize the molecular mechanisms responsible for regulating olfactory neuron gene expression, and to learn how they contribute to the formation, organization and function of this critical chemosensory system.
|
Margaret M. McCarthy,
Ph.D. 410-706-2655
Departments of Physiology and Psychiatry
Research:
|
Istvan Merchenthaler,
MD, PhD, DSc 410-706-1350
Department of Epidemiology and Anatomy/Neurobiology
Research: The role of estrogen and estrogen receptors as central regulators of reproduction and their role in neuroprotection (focal and global ischemia, aging, Alzheimer's disease).
|
Carys Mitchelmore,
Ph.D. 410-326-7283
Environmental Chemistry/Toxicology, Chesapeake Biological Lab, UMCES
Research: Aquatic toxicology; investigating molecular, biochemical and cellular responses of aquatic organisms to inorganic and organic pollutants.
|
Jessica Mong,
Ph.D. 410-706-4295
Department of Pharmacology and Experimental Therapeutics
Research: My laboratory is interested in the effects of gonadal steroids on neuronal-glial interactions in the developing and adult brain
|
John Ondov,
Ph.D. 410-405-1859
Chemistry and Biochemistry, UM College Park
Research: Measurement of aerosol particle composition and size distributions; instrument, multivariate receptor model, and intentional tracer methods development for quantifying human exposure and understanding the sources and fate of urban aerosol particles.
|
Edna F. R. Pereira,
Ph.D. 410-706-3563
Department of Pharmacology and Experimental Therapeutics
Research: Nicotinic cholinergic systems in the developing and mature brain of male and female rodents: Effects of toxicants, drugs of abuse, and drugs clinically used to treat neurodegenerative disorders.
|
Yun Qiu,
410-706-4535
Department of Pharmacology and Experimental Therapeutics
Research: protein phosphorylation and coupled post-translational modifications, mechanisms of drug resistance and tumor metastasis, cancer stem cells, mouse models of prostate cancer
|
William Randall,
Ph.D. 410-706-7530
Department of Pharmacology and Experimental Therapeutics
Research: Gene expression, molecular neurobiology of cholinergic proteins, synapse formation, synaptic protein targeting, synaptic protein turnover, cytoskeletal assembly of synaptic proteins, transcriptional control of acetylcholinesterase.
|
Christopher Rowe,
Ph.D. (410) 326-7227
Environmental Chemistry/Toxicology, Chesapeake Biological Lab, UMCES
Research: Environmental toxicology and ecology; physiological and reproductive ecology; bioenergetics; marine ecology; life history theory.
|
Horea Rus,
M.D., Ph.D. 410-328-5605
Neurology
Research: Dr. Rus’s lab focus is on investigating the role of complement in demyelinating diseases. In addition, Dr. Rus participates and directs clinical trials in investigating new drug therapies for Multiple Sclerosis.
|
Katherine Squibb,
Ph.D. 410-706-8196
Epidemiology and Preventive Medicine
Research: Human health effects of ambient air particles in urban and rural areas and biological mechanisms that control metal target organ toxicity and carcinogenicity.
|
Alan Tomkinson,
Ph.D. 410-706-2795
Radiation Oncology
Research: DNA replication, DNA repair and genetic recombination
|
Jordan E. Warnick,
Ph.D. 410-706-3026
Pharmacology & Experimental Therapeutics
Research: Medical Education, Pharmacology, Toxicology
|
Paul J. Yarowsky,
Ph.D. 410-706-3134
Department of Pharmacology & Experimental Therapeutics
Research: Interests of this laboratory are concerned with understanding how cognitive and neurodegeneration disorders such as Down syndrome (DS) and Alzheimer's disease may result from abnormal brain development and increased apoptosis. |